Id |
Subject |
Object |
Predicate |
Lexical cue |
T742 |
0-67 |
Sentence |
denotes |
Neural Systems Selectively Disrupted by Opiate and HIV Interactions |
T743 |
69-115 |
Sentence |
denotes |
Blood-Brain Barrier and the Neurovascular Unit |
T744 |
116-291 |
Sentence |
denotes |
Despite growing evidence on how opiates and HIV interact to impact the neuropathology of HIV, little is known about their interactive effects on the blood-brain barrier (BBB). |
T745 |
292-454 |
Sentence |
denotes |
BBB integrity and function are critical for maintaining CNS homeostasis, and mediating neuroimmune interactions with the periphery and drug delivery into the CNS. |
T746 |
455-565 |
Sentence |
denotes |
HIV and many individual HIV proteins can breakdown the BBB disrupting tight junction proteins (Dallasta et al. |
T747 |
566-584 |
Sentence |
denotes |
1999; Boven et al. |
T748 |
585-604 |
Sentence |
denotes |
2000; Andras et al. |
T749 |
605-625 |
Sentence |
denotes |
2003; Mahajan et al. |
T750 |
626-647 |
Sentence |
denotes |
2008; Banerjee et al. |
T751 |
648-667 |
Sentence |
denotes |
2010; Gandhi et al. |
T752 |
668-683 |
Sentence |
denotes |
2010; Xu et al. |
T753 |
684-702 |
Sentence |
denotes |
2012; Patel et al. |
T754 |
703-828 |
Sentence |
denotes |
2017) and decreasing transendothelial electrical resistance (TEER) (an in vitro measure of barrier integrity) (Mahajan et al. |
T755 |
829-848 |
Sentence |
denotes |
2008; Gandhi et al. |
T756 |
849-890 |
Sentence |
denotes |
2010; Mishra and Singh 2014; Patel et al. |
T757 |
891-1018 |
Sentence |
denotes |
2017), with resultant paracellular “leakage” of compounds/current between compromised barrier endothelial cells (Mahajan et al. |
T758 |
1019-1038 |
Sentence |
denotes |
2008; Gandhi et al. |
T759 |
1039-1055 |
Sentence |
denotes |
2010; Wen et al. |
T760 |
1056-1075 |
Sentence |
denotes |
2011; McLane et al. |
T761 |
1076-1097 |
Sentence |
denotes |
2014; Leibrand et al. |
T762 |
1098-1110 |
Sentence |
denotes |
2017, 2019). |
T763 |
1111-1246 |
Sentence |
denotes |
Although opioids can also impair the BBB through alterations in tight junction proteins and/or increased paracellular flux (Baba et al. |
T764 |
1247-1267 |
Sentence |
denotes |
1988; Mahajan et al. |
T765 |
1268-1284 |
Sentence |
denotes |
2008; Wen et al. |
T766 |
1285-1306 |
Sentence |
denotes |
2011; Leibrand et al. |
T767 |
1307-1467 |
Sentence |
denotes |
2019), others have found that it is morphine withdrawal, not the continued exposure to morphine, that most greatly disrupts BBB integrity (Sharma and Ali 2006). |
T768 |
1468-1627 |
Sentence |
denotes |
In addition to perturbing paracellular dynamics, morphine may also alter the expression and/or function of drug efflux proteins, such as P-glycoprotein (P-gp). |
T769 |
1628-1743 |
Sentence |
denotes |
Sub-chronic and chronic morphine exposure is reported to increase P-gp expression and/or function (Aquilante et al. |
T770 |
1744-1764 |
Sentence |
denotes |
2000; Mahajan et al. |
T771 |
1765-1784 |
Sentence |
denotes |
2008; Yousif et al. |
T772 |
1785-1806 |
Sentence |
denotes |
2008; Leibrand et al. |
T773 |
1807-1813 |
Sentence |
denotes |
2019). |
T774 |
1814-1911 |
Sentence |
denotes |
Alternatively, other investigators report no changes in P-gp with chronic exposure (Chaves et al. |
T775 |
1912-1983 |
Sentence |
denotes |
2016), while some see increases upon morphine withdrawal (Yousif et al. |
T776 |
1984-2003 |
Sentence |
denotes |
2012; Chaves et al. |
T777 |
2004-2010 |
Sentence |
denotes |
2016). |
T778 |
2011-2148 |
Sentence |
denotes |
Alterations in drug transport proteins would impact the central accumulation and efficacy of therapeutic drugs that are their substrates. |
T779 |
2149-2491 |
Sentence |
denotes |
Using a primary human brain microvascular endothelial cell (BMEC) and astrocyte co-culture model, Mahajan et al. (2008) were among the first to demonstrate that co-exposure to morphine and HIV-1 Tat resulted in greater increases in TNF-α and IL-8 levels and decreases in barrier tightness (measured by TEER) than either morphine or Tat alone. |
T780 |
2492-2732 |
Sentence |
denotes |
Morphine and Tat co-exposure also additively increased JAM-2, while zonula occludens-1 (ZO-1) levels were decreased by morphine or by Tat individually, and occludin protein levels were decreased by morphine alone but not Tat (Mahajan et al. |
T781 |
2733-2739 |
Sentence |
denotes |
2008). |
T782 |
2740-2901 |
Sentence |
denotes |
Using the inducible Tat transgenic mouse model, Leibrand et al. (2019), also demonstrated that HIV-1 Tat and morphine act independently to disrupt BBB integrity. |
T783 |
2902-3075 |
Sentence |
denotes |
In these studies, morphine, and to a lesser extent Tat, exposure increased the leakage of fluorescently labeled dextrans from the circulation into the brain (Leibrand et al. |
T784 |
3076-3097 |
Sentence |
denotes |
2017, 2019) (Fig. 3). |
T785 |
3098-3215 |
Sentence |
denotes |
Morphine exposure decreased the penetration of select ARVs in the brain, in a region-specific manner (Leibrand et al. |
T786 |
3216-3231 |
Sentence |
denotes |
2019) (Fig. 3). |
T787 |
3232-3435 |
Sentence |
denotes |
Morphine exposure also resulted in increased expression and function of the drug efflux transport protein, P-gp, suggesting a mechanism by which morphine decreased the ARV concentrations (Leibrand et al. |
T788 |
3436-3442 |
Sentence |
denotes |
2019). |
T789 |
3443-3589 |
Sentence |
denotes |
This finding suggests that morphine exposure could impact the efficient delivery of any therapeutic drug that is a substrate of P-gp into the CNS. |
T790 |
3590-3721 |
Sentence |
denotes |
Future research should also investigate morphine’s impact on other drug transport proteins important for ARV delivery to the brain. |
T791 |
3722-3823 |
Sentence |
denotes |
Fig. 3 Effects of HIV-1 Tat and morphine on BBB leakiness and on antiretroviral brain concentrations. |
T792 |
3824-4114 |
Sentence |
denotes |
After 14 days of Tat induction, there was a significant increase in the 10 kDa (Cascade Blue®) tracer leakage into the brain in Tat + placebo as compared to Tat − placebo mice (*p < 0.05) and in Tat − mouse brains upon exposure to morphine as compared to Tat − placebo mice (*p < 0.05) (a). |
T793 |
4115-4463 |
Sentence |
denotes |
There was a significant main effect of morphine, resulting in reduced integrity of the BBB and increased leakage of the higher molecular weight (40 kDa and 70 kDa) tracers in morphine-exposed groups as compared to the those groups (Tat + and Tat − together) not exposed to morphine (placebo) (#p < 0.05; significant main effect of morphine) (b, c). |
T794 |
4464-4623 |
Sentence |
denotes |
Data represent the fold change in mean fluorescence intensity ± SEM; n = 8 Tat−/placebo, n = 6 Tat+/placebo, n = 9 Tat−/morphine, and n = 7 Tat+/morphine mice. |
T795 |
4624-4799 |
Sentence |
denotes |
Additionally, morphine exposure increased horseradish peroxidase (HRP) extravasation from the vasculature into the perivascular space and/or parenchyma in the striatum (d, e). |
T796 |
4800-5037 |
Sentence |
denotes |
HRP antigenicity was detected by indirect immunofluorescence (red) in tissue sections counterstained with Hoechst 33342 (blue) to reveal cell nuclei and visualized by differential interference contrast (DIC)-enhanced confocal microscopy. |
T797 |
5038-5199 |
Sentence |
denotes |
HRP extravasation into the striatal perivascular space/parenchyma was especially prevalent in morphine-exposed mice (arrowheads; left-hand panels in e versus d). |
T798 |
5200-5470 |
Sentence |
denotes |
The dotted lines (············) indicate the approximate edge of the capillaries/post-capillary venules; while intermittent dotted lines (· · · · · · ·) indicate the approximate edge of a partly sectioned blood vessel that appears partially outside the plane of section. |
T799 |
5471-5538 |
Sentence |
denotes |
The asterisks (*) indicate white matter tracts within the striatum. |
T800 |
5539-5590 |
Sentence |
denotes |
Representative samples from ≥ n = 4 mice per group. |
T801 |
5591-5629 |
Sentence |
denotes |
All images are the same magnification. |
T802 |
5630-5648 |
Sentence |
denotes |
Scale bar = 10 μm. |
T803 |
5649-5706 |
Sentence |
denotes |
Antiretroviral tissue-to-plasma ratios in striatum (f–g). |
T804 |
5707-5925 |
Sentence |
denotes |
Irrespective of Tat exposure, morphine significantly reduced the levels of dolutegravir (f) and abacavir (g), but not lamivudine (h), within the striatum, as compared to placebo. (* p < 0.05; main effect for morphine). |
T805 |
5926-6151 |
Sentence |
denotes |
Data represent the tissue-to-plasma ratios ± SEM sampled from n = 9 Tat−/placebo, n = 9 Tat+/placebo, n = 6 Tat−/morphine, and n = 8 Tat+/morphine mice. (a–h) Modified and reprinted with permission from Leibrand et al. (2019) |
T806 |
6152-6314 |
Sentence |
denotes |
HIV, HIV-1 viral proteins, and opiate-induced barrier dysfunction is associated with increased infiltration of monocyte-derived macrophages (MDMs) into the brain. |
T807 |
6315-6461 |
Sentence |
denotes |
Enhanced influx of peripheral (infected) macrophages into the brain can serve to replenish viral reservoirs and further promote neuroinflammation. |
T808 |
6462-6600 |
Sentence |
denotes |
Several studies have examined the individual impact of HIV, Tat, or morphine on monocyte adhesion or migration into the CNS (Nottet et al. |
T809 |
6601-6616 |
Sentence |
denotes |
1996; Wu et al. |
T810 |
6617-6643 |
Sentence |
denotes |
2000; Fischer-Smith et al. |
T811 |
6644-6662 |
Sentence |
denotes |
2001; Pello et al. |
T812 |
6663-6684 |
Sentence |
denotes |
2006; Williams et al. |
T813 |
6685-6712 |
Sentence |
denotes |
2013a, 2014; Strazza et al. |
T814 |
6713-6734 |
Sentence |
denotes |
2016; Leibrand et al. |
T815 |
6735-6756 |
Sentence |
denotes |
2017; Chilunda et al. |
T816 |
6757-6763 |
Sentence |
denotes |
2019). |
T817 |
6764-6845 |
Sentence |
denotes |
However, fewer studies have examined the combined effects of HIV/Tat and opiates. |
T818 |
6846-7004 |
Sentence |
denotes |
Co-exposure of HIV-1 Tat and morphine on astrocytes increases the production of chemoattractants, primarily CCL2 and CCL5, and increases microglial migration. |
T819 |
7005-7065 |
Sentence |
denotes |
These effects were inhibited by MOR blockade (El-Hage et al. |
T820 |
7066-7073 |
Sentence |
denotes |
2006b). |
T821 |
7074-7228 |
Sentence |
denotes |
Co-exposure of Tat and morphine or buprenorphine to a BBB model increases monocyte transmigration in response to CCL5 and other chemokines (Mahajan et al. |
T822 |
7229-7262 |
Sentence |
denotes |
2008; Jaureguiberry-Bravo et. al. |
T823 |
7263-7269 |
Sentence |
denotes |
2016). |
T824 |
7270-7443 |
Sentence |
denotes |
In S. pneumoniae-infected mice, morphine and/or Tat exposure significantly enhances immune cell trafficking into the brain via actions at TLR2 and TLR4 (Dutta and Roy 2015). |
T825 |
7444-7540 |
Sentence |
denotes |
Taken together, BBB damage from HIV and/or opiates can disrupt the homeostasis within the brain. |
T826 |
7541-7868 |
Sentence |
denotes |
Breakdown of paracellular processes, through decreases in tight junction proteins and increased cellular adhesion proteins, increased leakage of circulating molecules into the brain and increased monocyte/MDM adhesion and transmigration into the brain, which if infected, can serve to replenish viral reservoirs within the CNS. |
T827 |
7869-7998 |
Sentence |
denotes |
Furthermore, alterations in drug transport proteins within the brain can decrease ARV efficacy by decreasing drug concentrations. |
T828 |
7999-8105 |
Sentence |
denotes |
Collectively, these changes serve to maintain HIV infection within the brain (see Fig. 4; Tables 1 and 2). |
T829 |
8106-8212 |
Sentence |
denotes |
Fig. 4 Schematic representation of the blood-brain barrier and other components of the neurovascular unit. |
T830 |
8213-8424 |
Sentence |
denotes |
Under normal conditions (represented above the dotted line), tight junctions are intact which restricts the leakage of paracellular, typically small hydrophilic, compounds, across the barrier and into the brain. |
T831 |
8425-8624 |
Sentence |
denotes |
Additionally, there is a basal expression of efflux transporters, such as P-glycoprotein (P-gp), which effluxes substrates out of the brain, serving to restrict overall accumulation within the brain. |
T832 |
8625-8819 |
Sentence |
denotes |
In the setting of HIV and opiate exposure (represented below the dotted line), there is a breakdown of the tight junction proteins and increased leakage of paracellular compounds into the brain. |
T833 |
8820-9141 |
Sentence |
denotes |
Additionally, opiate exposure increases efflux transporter expression, including P-gp and potentially breast cancer resistance protein (Bcrp), thereby restricting overall brain penetration of drugs (like many antiretroviral drugs) which are substrates for these transporters and in response to HIV and/or opioid exposure. |
T834 |
9143-9182 |
Sentence |
denotes |
White Matter/Oligodendroglial Pathology |
T835 |
9183-9234 |
Sentence |
denotes |
HIV can cause white matter damage (Gosztonyi et al. |
T836 |
9235-9256 |
Sentence |
denotes |
1994; Langford et al. |
T837 |
9257-9274 |
Sentence |
denotes |
2002; Xuan et al. |
T838 |
9275-9329 |
Sentence |
denotes |
2013) even with less severe forms of HAND (Chen et al. |
T839 |
9330-9348 |
Sentence |
denotes |
2009; Leite et al. |
T840 |
9349-9368 |
Sentence |
denotes |
2013; Correa et al. |
T841 |
9369-9375 |
Sentence |
denotes |
2015). |
T842 |
9376-9486 |
Sentence |
denotes |
Diffusion tensor magnetic resonance imaging (DTI) demonstrates white matter damage early in HAND (Ragin et al. |
T843 |
9487-9512 |
Sentence |
denotes |
2004; Stubbe-Drger et al. |
T844 |
9513-9531 |
Sentence |
denotes |
2012; Leite et al. |
T845 |
9532-9551 |
Sentence |
denotes |
2013; Correa et al. |
T846 |
9552-9558 |
Sentence |
denotes |
2015). |
T847 |
9559-9667 |
Sentence |
denotes |
White matter deficits are associated with cognitive impairment, including shortfalls in memory (Ragin et al. |
T848 |
9668-9708 |
Sentence |
denotes |
2005), executive function (Correa et al. |
T849 |
9709-9738 |
Sentence |
denotes |
2015), motor speed (Wu et al. |
T850 |
9739-9764 |
Sentence |
denotes |
2006; Stubbe-Drger et al. |
T851 |
9765-9825 |
Sentence |
denotes |
2012), and perhaps depression (Schmaal and van Velzen 2019). |
T852 |
9826-9928 |
Sentence |
denotes |
Preclinical studies in simian immunodeficiency virus- (SIV-) infected rhesus macaques (Marcario et al. |
T853 |
9929-9980 |
Sentence |
denotes |
2008) and HIV-infected humanized mice (Boska et al. |
T854 |
9981-10017 |
Sentence |
denotes |
2014) support the clinical findings. |
T855 |
10018-10110 |
Sentence |
denotes |
Injury to oligodendrocytes (OLs) can occur very early in the disease (see review, Liu et al. |
T856 |
10111-10118 |
Sentence |
denotes |
2016b). |
T857 |
10119-10230 |
Sentence |
denotes |
Viral proteins, including Tat, gp120, and Nef, have been implicated in OL injury in vitro (Kimura-Kuroda et al. |
T858 |
10231-10252 |
Sentence |
denotes |
1994; Bernardo et al. |
T859 |
10253-10271 |
Sentence |
denotes |
1997; Radja et al. |
T860 |
10272-10293 |
Sentence |
denotes |
2003; Nukuzuma et al. |
T861 |
10294-10310 |
Sentence |
denotes |
2012; Zou et al. |
T862 |
10311-10360 |
Sentence |
denotes |
2015), and in animal models in vivo (Radja et al. |
T863 |
10361-10380 |
Sentence |
denotes |
2003; Hauser et al. |
T864 |
10381-10397 |
Sentence |
denotes |
2009; Zou et al. |
T865 |
10398-10404 |
Sentence |
denotes |
2015). |
T866 |
10405-10495 |
Sentence |
denotes |
Importantly, Tat has been detected in OLs in the brains of AIDS patients (Del Valle et al. |
T867 |
10496-10502 |
Sentence |
denotes |
2000). |
T868 |
10503-10567 |
Sentence |
denotes |
HIV likely damages OLs through both direct and indirect actions. |
T869 |
10568-10643 |
Sentence |
denotes |
OLs lack CD4, and reports of OL infection by HIV are variable (Esiri et al. |
T870 |
10644-10665 |
Sentence |
denotes |
1991; Albright et al. |
T871 |
10666-10692 |
Sentence |
denotes |
1996; Wohlschlaeger et al. |
T872 |
10693-10801 |
Sentence |
denotes |
2009); thus, HIV infection of OLs is unlikely a major avenue of OL or white matter damage (discussed below). |
T873 |
10802-10989 |
Sentence |
denotes |
Alternatively, bystander damage to OLs through the production of “virotoxins” and “cellular toxins” (Nath 1999) by infected neighboring cells is more likely to be operative (Hauser et al. |
T874 |
10990-11006 |
Sentence |
denotes |
2009; Zou et al. |
T875 |
11007-11026 |
Sentence |
denotes |
2015; Jensen et al. |
T876 |
11027-11043 |
Sentence |
denotes |
2019; Zou et al. |
T877 |
11044-11050 |
Sentence |
denotes |
2019). |
T878 |
11051-11105 |
Sentence |
denotes |
ARVs also contribute to OL cytotoxicity (Jensen et al. |
T879 |
11106-11124 |
Sentence |
denotes |
2015; Festa et al. |
T880 |
11125-11144 |
Sentence |
denotes |
2019; Jensen et al. |
T881 |
11145-11151 |
Sentence |
denotes |
2019). |
T882 |
11152-11343 |
Sentence |
denotes |
HIV-1 Tat directly induces damage in isolated OLs through α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA)/N-methyl-D-aspartic acid (NMDA) receptor-dependent mechanisms (Zou et al. |
T883 |
11344-11413 |
Sentence |
denotes |
2015) and is also associated with abnormal Kv1.3 activity (Liu et al. |
T884 |
11414-11420 |
Sentence |
denotes |
2017). |
T885 |
11421-11517 |
Sentence |
denotes |
Immature OLs are preferentially targeted by Tat compared to differentiated OLs (Khurdayan et al. |
T886 |
11518-11535 |
Sentence |
denotes |
2004; Hahn et al. |
T887 |
11536-11552 |
Sentence |
denotes |
2012; Zou et al. |
T888 |
11553-11565 |
Sentence |
denotes |
2015, 2019). |
T889 |
11566-11814 |
Sentence |
denotes |
While the reasons why immature OLs are more susceptible to Tat are unclear, unlike mature OLs, Tat preferentially upregulates GSK-3β signaling in undifferentiated OLs by inhibiting Ca2+/calmodulin-dependent protein kinase II β (CaMKIIβ) (Zou et al. |
T890 |
11815-11821 |
Sentence |
denotes |
2019). |
T891 |
11822-11986 |
Sentence |
denotes |
Opioid abuse by itself can result in demyelination, leukoencephalopathy, and lesions in white matter (Offiah and Hall 2008; Eran and Barak 2009; Morales Odia et al. |
T892 |
11987-12004 |
Sentence |
denotes |
2010; Bora et al. |
T893 |
12005-12020 |
Sentence |
denotes |
2012; Li et al. |
T894 |
12021-12127 |
Sentence |
denotes |
2013), and the degree of myelin disruption correlates with the duration of opiate dependence (Ivers et al. |
T895 |
12128-12134 |
Sentence |
denotes |
2018). |
T896 |
12135-12352 |
Sentence |
denotes |
Chronic oxycodone exposure in rats causes some axonopathies and reduces the size of axonal fascicles, decreases myelin basic protein levels, and causes the accumulation of amyloid-β precursor protein (APP) (Fan et al. |
T897 |
12353-12359 |
Sentence |
denotes |
2018). |
T898 |
12360-12515 |
Sentence |
denotes |
Most preclinical studies have examined the effects of opioids and opioid receptor blockade on OL maturation and/or the timing of myelination (Hauser et al. |
T899 |
12516-12534 |
Sentence |
denotes |
1993; Knapp et al. |
T900 |
12535-12561 |
Sentence |
denotes |
1998; Stiene-Martin et al. |
T901 |
12562-12582 |
Sentence |
denotes |
2001; Sanchez et al. |
T902 |
12583-12601 |
Sentence |
denotes |
2008; Knapp et al. |
T903 |
12602-12629 |
Sentence |
denotes |
2009; Vestal-Laborde et al. |
T904 |
12630-12636 |
Sentence |
denotes |
2014). |
T905 |
12637-12715 |
Sentence |
denotes |
OLs can transiently express MORs and other opioid receptor types (Knapp et al. |
T906 |
12716-12740 |
Sentence |
denotes |
1998; Tryoen-Toth et al. |
T907 |
12741-12759 |
Sentence |
denotes |
2000; Knapp et al. |
T908 |
12760-12786 |
Sentence |
denotes |
2001; Stiene-Martin et al. |
T909 |
12787-12793 |
Sentence |
denotes |
2001). |
T910 |
12794-12921 |
Sentence |
denotes |
Selective MOR and possibly KOR activation can directly modulate the growth of OLs in vitro (Knapp and Hauser 1996; Knapp et al. |
T911 |
12922-12934 |
Sentence |
denotes |
1998, 2001). |
T912 |
12935-13054 |
Sentence |
denotes |
Despite long-standing evidence of white matter damage early during the infection even in asymptomatic PWH (Price et al. |
T913 |
13055-13072 |
Sentence |
denotes |
1988; Gray et al. |
T914 |
13073-13090 |
Sentence |
denotes |
1996; Chen et al. |
T915 |
13091-13116 |
Sentence |
denotes |
2009; Stubbe-Drger et al. |
T916 |
13117-13136 |
Sentence |
denotes |
2012; Jensen et al. |
T917 |
13137-13242 |
Sentence |
denotes |
2019), few studies have examined how opiate exposure affects OLs and myelin in neuroHIV (Tables 1 and 2). |
T918 |
13243-13388 |
Sentence |
denotes |
Increased demyelination is reported in SIV-infected rhesus macaques chronically treated with morphine (4× daily, up to 59 weeks) (Marcario et al. |
T919 |
13389-13395 |
Sentence |
denotes |
2008). |
T920 |
13396-13568 |
Sentence |
denotes |
Specifically, morphine-treated SIV macaques developed more subtle, focal, dysmyelinating lesions, with accumulations of macrophages in areas of myelin loss (Marcario et al. |
T921 |
13569-13624 |
Sentence |
denotes |
2008), as well as accompanying gliosis (Marcario et al. |
T922 |
13625-13650 |
Sentence |
denotes |
2008; Rivera-Amill et al. |
T923 |
13651-13672 |
Sentence |
denotes |
2010a; Bokhari et al. |
T924 |
13673-13679 |
Sentence |
denotes |
2011). |
T925 |
13680-13899 |
Sentence |
denotes |
Morphine exposure increased degeneration of OLs in Tat+ mice, which was accompanied by elevations in caspase-3 activation and TUNEL reactivity in OLs and reversible by naloxone or naltrexone, respectively (Hauser et al. |
T926 |
13900-13906 |
Sentence |
denotes |
2009). |
T927 |
13907-13970 |
Sentence |
denotes |
Although OLs can express MOR both in vivo (Stiene-Martin et al. |
T928 |
13971-14004 |
Sentence |
denotes |
2001) and in vitro (Hauser et al. |
T929 |
14005-14108 |
Sentence |
denotes |
2009), it remains unclear the extent to which MOR activation in OLs directly mediates HIV pathogenesis. |
T930 |
14110-14171 |
Sentence |
denotes |
Neural Progenitors as an HIV Reservoir and Target for Opioids |
T931 |
14172-14246 |
Sentence |
denotes |
Even though neural progenitors (Krathwohl and Kaiser 2004; Lawrence et al. |
T932 |
14247-14272 |
Sentence |
denotes |
2004; Rothenaigner et al. |
T933 |
14273-14294 |
Sentence |
denotes |
2007; Schwartz et al. |
T934 |
14295-14316 |
Sentence |
denotes |
2007; Balinang et al. |
T935 |
14317-14360 |
Sentence |
denotes |
2017), neuroblast cell lines (Ensoli et al. |
T936 |
14361-14386 |
Sentence |
denotes |
1994; Rothenaigner et al. |
T937 |
14387-14434 |
Sentence |
denotes |
2007), and/or immature astroglia (Atwood et al. |
T938 |
14435-14457 |
Sentence |
denotes |
1993; Tornatore et al. |
T939 |
14458-14476 |
Sentence |
denotes |
1994; Barat et al. |
T940 |
14477-14560 |
Sentence |
denotes |
2018) can harbor HIV infection (reviewed by Hauser and Knapp 2014; Putatunda et al. |
T941 |
14561-14679 |
Sentence |
denotes |
2019), the degree to which they are a source of active infection or serve as a latent viral reservoir (Blankson et al. |
T942 |
14680-14699 |
Sentence |
denotes |
2002; Bruner et al. |
T943 |
14700-14788 |
Sentence |
denotes |
2019) by retaining intact proviral DNA within incipient macroglial progeny is uncertain. |
T944 |
14789-14865 |
Sentence |
denotes |
In fact, spurious reports of HIV-infected adult neurons (Torres-Munoz et al. |
T945 |
14866-14891 |
Sentence |
denotes |
2001; Canto-Nogues et al. |
T946 |
14892-15049 |
Sentence |
denotes |
2005) may result from the retention of proviral genes that integrated into pluripotent neural progenitors or neuroblasts at earlier stages during maturation. |
T947 |
15050-15169 |
Sentence |
denotes |
Importantly, prolonged exposure to opioids can increase the production of HIV in human neural progenitor cells (hNPCs). |
T948 |
15170-15335 |
Sentence |
denotes |
Exposure of R5-tropic HIVBaL-infected hNPCs to morphine continuously for 21 d increased viral production compared to HIVBaL infection alone in vitro (Balinang et al. |
T949 |
15336-15342 |
Sentence |
denotes |
2017). |
T950 |
15343-15450 |
Sentence |
denotes |
Besides being able to infect hNPCs, HIV may also affect their maturation and the fate of neural stem cells. |
T951 |
15451-15515 |
Sentence |
denotes |
That HIV or gp120 can inhibit adult neurogenesis (Okamoto et al. |
T952 |
15516-15532 |
Sentence |
denotes |
2007; Lee et al. |
T953 |
15533-15555 |
Sentence |
denotes |
2013; Putatunda et al. |
T954 |
15556-15640 |
Sentence |
denotes |
2018) has been the topic of past reviews (Schwartz and Major 2006; Venkatesan et al. |
T955 |
15641-15658 |
Sentence |
denotes |
2007; Peng et al. |
T956 |
15659-15735 |
Sentence |
denotes |
2008, 2011; Ferrell and Giunta 2014; Hauser and Knapp 2014; Putatunda et al. |
T957 |
15736-15742 |
Sentence |
denotes |
2019). |
T958 |
15743-15950 |
Sentence |
denotes |
How HIV inhibits the self-renewal, tripotential differentiation, and survival of neural progenitors/stem cells or the genesis of adult neurons in the subgranular zone (SGZ) of the dentate gyrus is uncertain. |
T959 |
15951-16128 |
Sentence |
denotes |
HIV and gp120 [via actions at the same chemokine receptor(s) (Tran and Miller 2005; Li and Ransohoff 2008)] are proposed to modulate the adult neurogenesis via Notch (Fan et al. |
T960 |
16129-16254 |
Sentence |
denotes |
2016), by obstructing a cell cycle checkpoint via the activation MAPK-activated protein kinase 2 and Cdc25B/C (Okamoto et al. |
T961 |
16255-16332 |
Sentence |
denotes |
2007), or through signaling by platelet-derived growth factor BB (Chao et al. |
T962 |
16333-16358 |
Sentence |
denotes |
2014) or BDNF (Lee et al. |
T963 |
16359-16365 |
Sentence |
denotes |
2013). |
T964 |
16366-16655 |
Sentence |
denotes |
The extent that HIV regulates the genesis of neural progenitors within the subventricular zone of the developing CNS through similar mechanisms as in the adult SGZ of the dentate gyrus is uncertain—even though HIV disrupts the generation of neurons and glia during maturation or in adults. |
T965 |
16656-16825 |
Sentence |
denotes |
For example, MAPK/ERK1/2 enhances p53- and p21-dependent downregulation of cyclin D1 hindering progression through the G1 phase of the cell cycle in hNPCs (Mishra et al. |
T966 |
16826-16844 |
Sentence |
denotes |
2010; Malik et al. |
T967 |
16845-16851 |
Sentence |
denotes |
2014). |
T968 |
16852-17024 |
Sentence |
denotes |
Importantly, opioids too can affect the genesis of neurons and glia during maturation or in the adult directly via convergent pathways (Hauser and Knapp 2018; Kibaly et al. |
T969 |
17025-17153 |
Sentence |
denotes |
2018) suggesting yet another site of opioid and HIV interactions in dysregulating the creation and fate of new neurons and glia. |
T970 |
17154-17251 |
Sentence |
denotes |
Few studies have examined the interplay between opioids, neural progenitors and HIV/HIV proteins. |
T971 |
17252-17485 |
Sentence |
denotes |
Sustained exposure (4 d) to morphine (500 nM) and Tat1–72 (100 nM) decreased the viability of MOR-expressing striatal glial precursors, and to a lesser extent astrocytes, and this coincided with caspase-3 activation (Khurdayan et al. |
T972 |
17486-17492 |
Sentence |
denotes |
2004). |
T973 |
17493-17707 |
Sentence |
denotes |
By contrast, comparably administered morphine or Tat alone was sufficient to decrease the viability of immature glia/glial progenitors in spinal cord cultures, while Tat and morphine failed to interact (Buch et al. |
T974 |
17708-17714 |
Sentence |
denotes |
2007). |
T975 |
17715-17944 |
Sentence |
denotes |
Collectively, these findings were the first to indicate that opioid and/or Tat could enhance programmed cell death in subpopulations of glial precursors in a developmentally regulated and region-dependent manner (Khurdayan et al. |
T976 |
17945-17962 |
Sentence |
denotes |
2004; Buch et al. |
T977 |
17963-17969 |
Sentence |
denotes |
2007). |
T978 |
17970-18263 |
Sentence |
denotes |
In human glial progenitors, co-administering morphine (500 nM) increased the antiproliferative effects of Tat (12–48 h) or conditioned medium from HIV-1SF162-infected MDMs (12 h), while paradoxically reversing the antiproliferative effects from HIV-1IIIB conditioned medium (12 h) (Hahn et al. |
T979 |
18264-18270 |
Sentence |
denotes |
2012). |
T980 |
18271-18479 |
Sentence |
denotes |
In these studies, Tat or HIV exposure reduced the proliferation of Sox2+ and Olig2+ undifferentiated glial and oligodendroglial progenitors, respectively, while progenitor viability was unchanged (Hahn et al. |
T981 |
18480-18486 |
Sentence |
denotes |
2012). |
T982 |
18487-18758 |
Sentence |
denotes |
In human neural progenitor cells (hNPCs), sustained infection with R5-tropic HIVBaL increased the proliferation and premature differentiation of hNPCs into both neurons and astrocytes, and both measures were significantly enhanced by morphine co-exposure (Balinang et al. |
T983 |
18759-18765 |
Sentence |
denotes |
2017). |
T984 |
18766-18821 |
Sentence |
denotes |
Importantly, immunoneutralizing antibodies (Hahn et al. |
T985 |
18822-18883 |
Sentence |
denotes |
2012) or the selective antagonist, maraviroc (Balinang et al. |
T986 |
18884-19057 |
Sentence |
denotes |
2017), were able to significantly attenuate the consequences of R5-tropic HIV infection on hNPC differentiation and fate confirming a direct role of CCR5 in these processes. |
T987 |
19058-19226 |
Sentence |
denotes |
Lastly, decreases in the proliferation of hNPCs seen with morphine and Tat are, in part, regulated by ERK1/2-dependent increases in p53 and p21 expression (Malik et al. |
T988 |
19227-19319 |
Sentence |
denotes |
2014) and can be modulated by PDGF BB suggesting a possible therapeutic target (Malik et al. |
T989 |
19320-19326 |
Sentence |
denotes |
2011). |
T990 |
19327-19521 |
Sentence |
denotes |
Thus, morphine can exaggerate R5-tropic HIV-induced alterations in the maturation and fate of human and rodent NPCs, thereby further disrupting the balance of neural cell types and CNS function. |